L-OAT
A proposed framework for quantitative iris characterization using structural imaging, optical features and multimodal assessment.
VIEW RESEARCH ↗
STRATEGIC INDUSTRIAL CO-DEVELOPMENT
Clinical insight.
Industrial innovation.
An invitation to established laser manufacturers, MedTech venture builders and operating partners to co-develop clinically informed ophthalmic technology.
THE DEVELOPMENT OPPORTUNITY
Clinical experience identifies the opportunity. Industry creates the platform.
The opportunity is not a finished laser device for sale. It is a defined clinical and scientific starting point for an industrial development program.
Lumineyes Global seeks a partner prepared to lead engineering feasibility, platform design, verification, regulatory planning and commercialization.Potential approaches include independent optical delivery solutions or dedicated OEM systems.
WHERE A PARTNER CAN LEAD
A focused program with clear industrial leadership.
We seek an accountable development partner, not merely a component supplier or consulting service.
01 / DESIGN
OPTICAL & LASER ENGINEERING
Translate clinical requirements into technical concepts, engineering feasibility studies and measurable optical specifications.
02 / DEVELOPMENT
DEVICE & REGULATORY EXECUTION
Lead prototype development, engineering verification, quality systems, clinical development strategy and regulatory planning.
03 / GROWTH
CAPITAL & COMMERCIAL SCALE
Establish an investable industrial program with development milestones, manufacturing strategy and negotiated commercial participation.
A PARTNERSHIP, NOT A PURCHASE ORDER
We bring the clinical foundation. You lead the industrial realization.
Lumineyes Global invites qualified companies and operating partners to explore a joint development structure built around complementary capabilities, technical feasibility and long-term commercialization.
Early discussions remain non-confidential. Detailed proprietary concepts and technical know-how are reserved for an agreed intellectual property and development framework.
POTENTIAL COLLABORATION FRAMEWORK
- Clinical foundation: Ophthalmic experience, research concepts and scientific participation.
- Industrial leadership: Engineering, R&D investment, manufacturing, quality systems and regulatory strategy.
- Initial milestone: Independently defined laboratory feasibility and engineering verification.
- Commercial structure: Negotiated co-development, licensing, equity participation or other mutually agreed partnership arrangements.
SELECTED ORIGINAL RESEARCH FRAMEWORKS
A scientific foundation for what comes next.
Selected Lumineyes research concepts supporting future optical engineering, clinical characterization and ophthalmic technology development.
L-SAFE
A structured anterior-segment safety framework supporting staged evaluation and clinical reassessment.
VIEW RESEARCH ↗LIPS
An original framework for iris pigmentation classification and characterization of spatial pigment heterogeneity.
VIEW RESEARCH ↗SSMM
Selective Stromal Melanin Modulation: a conceptual approach to preferential melanin interaction and controlled laser–tissue response.
VIEW RESEARCH ↗
INVITATION TO QUALIFIED INDUSTRY PARTNERS
Ready to lead an ophthalmic laser development venture?
We welcome proposals from ophthalmic laser manufacturers, MedTech venture builders, technical co-founders and strategic investors with the capabilities to engineer, finance and advance a medical technology platform.
INITIATE A STRATEGIC DISCUSSION ↗Institutional and professional inquiries only.